Cardio-oncology & other

Differential associations of cardiorenal-inflammatory markers with cardiac and cancer mortality in cancer survivors

Eur Heart J Qual Care Clin OutcomesPublished prospective analysis

Authors' conclusion

In cancer survivors, increased cardiac stress was more strongly associated with cardiac mortality whereas systemic inflammation was more strongly associated with cancer mortality. Renal dysfunction was similarly associated with both cardiac and cancer mortality.

Study context

Population
U.S. cancer survivors aged ≥ 20 years from the NHANES cohort (1999–2004), with follow-up through 2019mean age: 67.5 years, 52.1% women, analyses biomarker-specific (participants with missing values for a given biomarker excluded from that analysis)
Participants
1,384 survivors
Exposure
Associations of cardiorenal-inflammatory biomarkers (NT-proBNP, high-sensitivity troponin-T (hs-TnT), high-sensitivity troponin I (hs-TnI), urinary albumin-to-creatinine ratio (UACR), fractional excretion of albumin (FEalb), C-reactive protein (CRP)) with cardiac vs. cancer mortality

Main finding

As reported in the abstract

Cardiac and cancer deaths · median [P25-P75] follow-up of 11.8 [5.1-16.8] years

Cardiac deaths

199

14.4%

Cancer deaths

259

18.7%

Observational data: associations, not effects.

Further findings

Association of biomarkers with cardiac and cancer mortality (multivariable models)

All biomarkers except CRP significantly associated with cardiac mortality
P ≤ 0.001 for all
All biomarkers except cardiac troponins significantly associated with cancer mortality
P ≤ 0.001 for all

Formal comparison of associations with cardiac vs. cancer mortality

Cardiac troponins and NT-proBNP stronger associations with cardiac mortality than cancer mortality
P for difference ≤ 0.006
CRP stronger associations with cancer mortality than cardiac mortality
P for difference < 0.001
UACR and FEalb similarly associated with both cardiac and cancer mortality
P for difference > 0.7

Original publication

Differential associations of cardiorenal-inflammatory markers with cardiac and cancer mortality in cancer survivors. Eur Heart J Qual Care Clin Outcomes. Published 13 November 2025. doi:10.1093/ehjqcco/qcaf134

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.